Glaukos Corp (GKOS) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Glaukos Corp

NYSE | GKOS

86.86

USD

-13.18 (-13.17%)

AT CLOSE (AS OF Apr 3, 2025)

$5.7B

MARKET CAP

P/E Ratio

-2.77

EPS

$164

52 Week High

$92

52 Week Low

LIFE SCIENCES

Sector

GKOS Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

GKOS Technicals

Tags:

GKOS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$289M
Total Revenue	$378M
Cost Of Revenue	$382M
Costof Goods And Services Sold	$94M
Operating Income	-$122M
Selling General And Administrative	$261M
Research And Development	$136M
Operating Expenses	$412M
Investment Income Net	-
Net Interest Income	$1.1M
Interest Income	$11M
Interest Expense	$10M
Non Interest Income	$378M
Other Non Operating Income	-
Depreciation	$11M
Depreciation And Amortization	$27M
Income Before Tax	-$146M
Income Tax Expense	$771K
Interest And Debt Expense	$28M
Net Income From Continuing Operations	-$146M
Comprehensive Income Net Of Tax	-$145M
Ebit	-$122M
Ebitda	-$95M
Net Income	-$146M

Revenue & Profitability

Earnings Performance

GKOS Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$975M
Total Current Assets	$450M
Cash And Cash Equivalents At Carrying Value	$170M
Cash And Short Term Investments	$170M
Inventory	$58M
Current Net Receivables	$61M
Total Non Current Assets	$519M
Property Plant Equipment	$98M
Accumulated Depreciation Amortization Ppe	$45M
Intangible Assets	$330M
Intangible Assets Excluding Goodwill	$263M
Goodwill	$66M
Investments	$149M
Long Term Investments	-
Short Term Investments	$149M
Other Current Assets	$12M
Other Non Current Assets	-
Total Liabilities	$208M
Total Current Liabilities	$75M
Current Accounts Payable	$13M
Deferred Revenue	-
Current Debt	$1.1M
Short Term Debt	-
Total Non Current Liabilities	$147M
Capital Lease Obligations	$69M
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$103M
Other Current Liabilities	$62M
Other Non Current Liabilities	$22M
Total Shareholder Equity	$767M
Treasury Stock	$132K
Retained Earnings	-$745M
Common Stock	$56K
Common Stock Shares Outstanding	$56M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	-$61M
Payments For Operating Activities	$13M
Proceeds From Operating Activities	-
Change In Operating Liabilities	$21K
Change In Operating Assets	$43M
Depreciation Depletion And Amortization	$36M
Capital Expenditures	$6.3M
Change In Receivables	$22M
Change In Inventory	$19M
Profit Loss	-$146M
Cashflow From Investment	$48M
Cashflow From Financing	$92M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	$53M
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$47M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$146M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$289M
Total Revenue	$378M
Cost Of Revenue	$382M
Costof Goods And Services Sold	$94M
Operating Income	-$122M
Selling General And Administrative	$261M
Research And Development	$136M
Operating Expenses	$412M
Investment Income Net	-
Net Interest Income	$1.1M
Interest Income	$11M
Interest Expense	$10M
Non Interest Income	$378M
Other Non Operating Income	-
Depreciation	$11M
Depreciation And Amortization	$27M
Income Before Tax	-$146M
Income Tax Expense	$771K
Interest And Debt Expense	$28M
Net Income From Continuing Operations	-$146M
Comprehensive Income Net Of Tax	-$145M
Ebit	-$122M
Ebitda	-$95M
Net Income	-$146M

GKOS Profile

Glaukos Corp Profile

Sector: LIFE SCIENCES

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, is focused on developing new therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company is headquartered in San Clemente, California.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	742,693,504
NVDA	$101.80	-7.81%	$2.68T	334,149,797
INTC	$22.43	2.05%	$95.85B	240,924,655
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	210,875,217

Symbol	Price	Change %	Market Cap	Volume
JNJ	$160.56	3.35%	$399.65B	9,908,361
PG	$172.57	1.81%	$399.61B	6,993,394
NVO	$67.12	-1.65%	$308.32B	8,797,694
AZN	$74.03	2.50%	$225.70B	6,150,517
MRK	$86.38	-0.25%	$220.07B	12,113,104

Symbol	Price	Change %	Market Cap	Volume
VCIG	$5.99	1,796.17%	$26.40M	310,904
MKTW	$9.19	1,684.81%	$19.91M	117,875
PTIX	$0.42	84.14%	$4.04M	177,332,811
MRM	$0.65	74.84%	$2.91M	51,693,935
OSRH	$2.47	68.03%	$40.06M	89,471,971

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,865,554
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669

Quick Links

GKOS $86.86 (-13.17%) Quote details